Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cardiol Therapeutics Inc. (CRDL) had Operating Cash Flow per Share of $-0.26 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-26.77M |
|
-- |
|
-- |
|
$29.39M |
|
$-29.39M |
|
$2.63M |
|
$-26.77M |
|
$-26.77M |
|
$-26.77M |
|
$-26.77M |
|
$-26.77M |
|
$-26.77M |
|
$-29.39M |
|
$-29.12M |
|
71.57M |
|
71.57M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$23.11M |
|
$0.14M |
|
$0.14M |
|
$23.25M |
|
$5.12M |
|
$0.09M |
|
$0.09M |
|
$5.21M |
|
$18.05M |
|
$18.05M |
|
$18.05M |
|
82.61M |
|
| Cash Flow Statement Financials | |
$-18.29M |
|
$-0.02M |
|
$13.75M |
|
$25.49M |
|
$22.32M |
|
$-3.18M |
|
$10.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-148.32% |
|
-148.32% |
|
-115.11% |
|
-147.57% |
|
$0.22 |
|
$-0.26 |
|
|
Operating Cash Flow per Share |
$-0.26 |